Viela Bio ^Company

Clinical-stage biotechnology companyAccording to 2 sourcesViela Bio Inc Viela Bio, Inc. operates as a clinical-stage biotechnology company. The Company develops and commercializes therapeutics and medicines for the treatment of patients with autoimmune and severe inflammatory diseases.Viela Bio Inc - Company Pr…bloomberg.comViela Bio Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for severe inflammation and autoimmune diseases. Its product pipeline includes Inebilizumab, VIB4920 and VIB7734. Inebilizumab is a humanized mAb that binds to and depletes CD19+ B cells including plasmablasts and plasma cells.Viela Bio, Inc.: Shareholder…marketscreener.comFeedback